跳至主要内容
临床试验/NCT03295162
NCT03295162已完成1 期

Effects of Melatonin as a Novel Antioxidant and Free Radicals Scavenger in Neonatal Sepsis

Mohamed Hussein Metwally0 个研究点目标入组 55 人开始时间: 2015年11月26日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
55
主要终点
Melatonin as an antioxidant and free radicals scavenger in Neonatal sepsis

研究概览

简要总结

Assess the efficacy of melatonin as an adjuvant in the treatment of free radical disease in septic preterms receiving melatonin compared to those on conventional treatment through measuring the level of Malondialdehyde as a marker of oxidative stress and by comparing other clinical and laboratory parameters of sepsis in both groups.

详细描述

This is a randomized controlled trial. It will be provisionally conducted on 55 neonates admitted to the neonatal intensive care units (NICUs) of Ain Shams University Hospitals, Cairo, Egypt.

Inclusion criteria:

The study will include:Preterm infants (less than 37 weeks gestational age). Evidence of neonatal sepsis.

Exclusion Criteria: Neonate with evidence of any of the following will be excluded:

Infants with hypoxic ischemic encephalopathy. Infants on nothing per os. Infants with high oxygen needs either on invasive or non-invasive mechanical ventilation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
1 Day 至 28 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Preterm infants ( less than 37 weeks gestational age). Evidence of neonatal sepsis

排除标准

  • Infants with hypoxic ischemic encephalopath Infants on nothing per os. Infants with high oxygen needs either on invasive or non-invasive mechanical ventilation.

研究组 & 干预措施

Sepsis A Group

Experimental

neonates diagnosed with Sepsis and will receive melatonin. 10 mg product as a total dose of 20 mg .together with conventional treatment of Neonatal sepsis

干预措施: Melatonin 10 mg (Drug)

Sepsis A Group

Experimental

neonates diagnosed with Sepsis and will receive melatonin. 10 mg product as a total dose of 20 mg .together with conventional treatment of Neonatal sepsis

干预措施: Conventional treatment of neonatal sepsis (Combination Product)

Sepsis B Group

Sham Comparator

neonates diagnosed with Sepsis and willnot receive melatonin., they will recieve only the conventional treatment of Neonatal Sepsis

干预措施: Conventional treatment of neonatal sepsis (Combination Product)

结局指标

主要结局

Melatonin as an antioxidant and free radicals scavenger in Neonatal sepsis

时间窗: 3 days

efficacy of melatonin as an adjuvant in the treatment of free radical disease in septic preterms receiving melatonin compared to those on conventional treatment through measuring the level of Malondialdehyde as a marker of oxidative stress

次要结局

  • melatonin as an adjuvant in management of neonatal sepsis(3 days)

研究者

发起方
Mohamed Hussein Metwally
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Mohamed Hussein Metwally

Assistant Lecturer

Ain Shams University

相似试验